Latest news
Opal Therapeutics Secures $1.25 Million NSF Award To Expand Uterine Organoid Platform - Pulse 2.0Pulse 2.0 · Thu, 06 Aug 2026 14:16:15 GMTIQVIA partners with Medera to advance cardiac gene therapy and human organoid platform - AllSciAllSci · Wed, 05 Aug 2026 12:01:45 GMTLunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - TradingViewTradingView · Tue, 04 Aug 2026 19:28:00 GMT